Moderna, Inc. (MRNA)
USD 24.19
(-3.68%)
USD 24.19
(-3.68%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.23 Billion USD | -145.0% |
| 2022 | 9.42 Billion USD | -29.15% |
| 2021 | 13.29 Billion USD | 1842.27% |
| 2020 | -763.14 Million USD | -39.84% |
| 2019 | -545.72 Million USD | -32.05% |
| 2018 | -413.26 Million USD | -53.43% |
| 2017 | -269.35 Million USD | -20.37% |
| 2016 | -223.77 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.26 Billion USD | -21200.0% |
| 2024 Q2 | -1.36 Billion USD | -7.66% |
| 2023 Q4 | 6 Million USD | 100.3% |
| 2023 FY | -4.23 Billion USD | -145.0% |
| 2023 Q2 | -1.86 Billion USD | -410.11% |
| 2023 Q3 | -2.01 Billion USD | -7.77% |
| 2023 Q1 | -366 Million USD | -123.16% |
| 2022 Q2 | 2.44 Billion USD | -42.11% |
| 2022 Q4 | 1.58 Billion USD | 35.51% |
| 2022 FY | 9.42 Billion USD | -29.15% |
| 2022 Q1 | 4.22 Billion USD | -21.87% |
| 2022 Q3 | 1.16 Billion USD | -52.35% |
| 2021 Q1 | 1.26 Billion USD | 560.3% |
| 2021 FY | 13.29 Billion USD | 1842.27% |
| 2021 Q4 | 5.41 Billion USD | 52.05% |
| 2021 Q3 | 3.55 Billion USD | 16.2% |
| 2021 Q2 | 3.06 Billion USD | 141.86% |
| 2020 FY | -763.14 Million USD | -39.84% |
| 2020 Q3 | -235.11 Million USD | -92.52% |
| 2020 Q4 | -275.03 Million USD | -16.98% |
| 2020 Q1 | -130.86 Million USD | -0.23% |
| 2020 Q2 | -122.12 Million USD | 6.67% |
| 2019 Q1 | -141.83 Million USD | 7.32% |
| 2019 Q4 | -130.55 Million USD | 0.23% |
| 2019 Q3 | -130.85 Million USD | 9.09% |
| 2019 Q2 | -143.93 Million USD | -1.48% |
| 2019 FY | -545.72 Million USD | -32.05% |
| 2018 Q3 | -85.81 Million USD | 11.54% |
| 2018 Q1 | -77.4 Million USD | -85.05% |
| 2018 FY | -413.26 Million USD | -53.43% |
| 2018 Q4 | -153.03 Million USD | -78.32% |
| 2018 Q2 | -97.01 Million USD | -25.34% |
| 2017 Q4 | -41.82 Million USD | 38.37% |
| 2017 Q3 | -67.87 Million USD | 14.98% |
| 2017 Q2 | -79.82 Million USD | 0.0% |
| 2017 Q1 | -79.82 Million USD | 0.0% |
| 2017 FY | -269.35 Million USD | -20.37% |
| 2016 FY | -223.77 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -1687.047% |
| Alkermes plc | 414.12 Million USD | 1123.611% |
| Agenus Inc. | -159.54 Million USD | -2556.864% |
| Aptorum Group Limited | -10.52 Million USD | -40181.926% |
| Ardelyx, Inc. | -63.27 Million USD | -6599.222% |
| Dyadic International, Inc. | -8.22 Million USD | -51408.316% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -355520.805% |
| Lantern Pharma Inc. | -17.87 Million USD | -23611.276% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -21000.268% |
| Novavax, Inc. | -566.51 Million USD | -648.264% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -5708.52% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -5057.185% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -21729.68% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -40030.645% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -7879.087% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -1014.072% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -17339.702% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -11093.852% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -3186.352% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -4951.6% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -24068.995% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -9531.902% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -16962.47% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -2948.96% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -1402.259% |
| AlloVir, Inc. | -181.33 Million USD | -2237.714% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -1967.785% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -14388.345% |
| Bicycle Therapeutics plc | -189.94 Million USD | -2131.687% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -2367.663% |
| ChromaDex Corporation | -5.59 Million USD | -75609.948% |
| Chimerix, Inc. | -93.06 Million USD | -4454.881% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -9303.846% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -3552.453% |
| CRISPR Therapeutics AG | -222.53 Million USD | -1804.843% |
| Precision BioSciences, Inc. | -43.73 Million USD | -9592.244% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -2125.068% |
| Fortress Biotech, Inc. | -142.34 Million USD | -2878.039% |
| Fortress Biotech, Inc. | -142.34 Million USD | -2878.039% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -4239.059% |
| ImmuCell Corporation | -5.74 Million USD | -73646.39% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -3053.337% |
| Immix Biopharma, Inc. | -16.14 Million USD | -26162.13% |
| Incyte Corporation | 620.52 Million USD | 783.131% |
| Innoviva, Inc. | 176.7 Million USD | 2498.859% |
| IO Biotech, Inc. | -91.44 Million USD | -4535.675% |
| Jaguar Health, Inc. | -34.29 Million USD | -12261.844% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -2394.395% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 35596.567% |
| ContextLogic Inc. | -328 Million USD | -1192.378% |
| MiMedx Group, Inc. | 37.11 Million USD | 11520.951% |
| MEI Pharma, Inc. | 14.54 Million USD | 29250.048% |
| NextCure, Inc. | -67.63 Million USD | -6167.28% |
| Onconetix, Inc. | -36.03 Million USD | -11663.695% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -10062.056% |
| Opthea Limited | -191.84 Million USD | -2109.622% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -153943.226% |
| Vaxcyte, Inc. | -468.04 Million USD | -805.69% |
| PDS Biotechnology Corporation | -43.04 Million USD | -9747.78% |
| Precigen, Inc. | -88.92 Million USD | -4667.046% |
| Pharming Group N.V. | -4.87 Million USD | -86772.872% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -2433.59% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -14145.866% |
| PureTech Health plc | -146.19 Million USD | -2799.473% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -20587.131% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -1699.251% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -17339.702% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -1447.052% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -14365.108% |
| Acelyrin, Inc. | -422.06 Million USD | -904.35% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -32873259.628% |
| Summit Therapeutics Inc. | -89.73 Million USD | -4623.857% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -11336.974% |
| Senti Biosciences, Inc. | -92.72 Million USD | -4471.484% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -3593.377% |
| Elevation Oncology, Inc. | -45.44 Million USD | -9227.759% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -12270.502% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -107432.937% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -133960.721% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -12737.285% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -49764.722% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -6134.19% |
| Seer, Inc. | -103.46 Million USD | -3997.117% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -6346.266% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -5792.984% |
| ESSA Pharma Inc. | -32.13 Million USD | -13091.592% |
| GlycoMimetics, Inc. | -39.27 Million USD | -10693.045% |
| GT Biopharma, Inc. | -13.57 Million USD | -31124.219% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -1833.665% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -9064.217% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 4982.965% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -7368.419% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -8130.109% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -42555.981% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -740.546% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -61352.595% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -8262.101% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -1532.526% |
| Aptose Biosciences Inc. | -52.35 Million USD | -7996.493% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -29295.093% |
| Soligenix, Inc. | -7.69 Million USD | -54966.68% |
| Century Therapeutics, Inc. | -146.54 Million USD | -2792.607% |
| Kura Oncology, Inc. | -165.8 Million USD | -2456.633% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -4435.727% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -50855.644% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -170714.53% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -65276.311% |
| Autolus Therapeutics plc | -195.02 Million USD | -2073.534% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -4907.265% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -5654.663% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -19956.778% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -1767.113% |
| GRI Bio, Inc. | -11.38 Million USD | -37126.662% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -93772.177% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -3131.118% |
| IGM Biosciences, Inc. | -263.46 Million USD | -1508.967% |
| INmune Bio, Inc. | -29.74 Million USD | -14153.051% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -3732.211% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -11033.196% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -26427.969% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -26778.743% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -6838.034% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -3842.449% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -1435.836% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -1986.132% |
| Verastem, Inc. | -92.08 Million USD | -4503.406% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -8893.317% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -2201.99% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -3480.841% |
| Histogen Inc. | -10.64 Million USD | -39728.996% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -27297.951% |
| Surrozen, Inc. | -45.78 Million USD | -9159.502% |
| Organovo Holdings, Inc. | -15.08 Million USD | -27998.9% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -83177.082% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -7050.633% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -8164.124% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -16668.196% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -55436.319% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -2374.852% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -8649.595% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -5320.37% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -27750.095% |
| Apollomics, Inc. | -54.83 Million USD | -7630.605% |
| Amarin Corporation plc | -67.58 Million USD | -6171.823% |
| Mesoblast Limited | -58.79 Million USD | -7109.919% |
| Turnstone Biologics Corp. | -59.03 Million USD | -7080.851% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -2460.865% |
| Synaptogenix, Inc. | -8.31 Million USD | -50887.184% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -28962.114% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -4523.136% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -88369.792% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -47900.082% |
| Exelixis, Inc. | 170.88 Million USD | 2580.616% |
| Better Therapeutics, Inc. | -38.26 Million USD | -10978.877% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -2633.728% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -719.731% |
| NLS Pharmaceutics AG | -11.8 Million USD | -35802.239% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -52611.385% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -14033.298% |
| Gritstone bio, Inc. | -154.63 Million USD | -2641.312% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -6055.879% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -24656.101% |
| Avid Bioservices, Inc. | -18.67 Million USD | -22595.149% |
| Insmed Incorporated | -709.62 Million USD | -497.357% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -26917.573% |
| MediWound Ltd. | -15.29 Million USD | -27624.003% |
| OmniAb, Inc. | -69.41 Million USD | -6006.397% |
| Alector, Inc. | -151.74 Million USD | -2693.594% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -3825.618% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -8028.787% |
| Zai Lab Limited | -366.57 Million USD | -1056.386% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -1238.165% |
| Aura Biosciences, Inc. | -84.99 Million USD | -4887.587% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -1626.687% |
| Immunic, Inc. | -99.22 Million USD | -4172.195% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -2861.064% |
| Veracyte, Inc. | -85.79 Million USD | -4840.847% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -1404.178% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -29731.105% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -61442.285% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -22456.731% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 832.656% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -16554.225% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 11024.695% |
| TG Therapeutics, Inc. | 20.63 Million USD | 20644.758% |
| Galecto, Inc. | -39.9 Million USD | -10522.729% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -9975.106% |
| Fortrea Holdings Inc. | 63.1 Million USD | 6817.908% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -2918.263% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -14578.994% |
| XBiotech Inc. | -37.51 Million USD | -11200.986% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -6055.879% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -6215.554% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -3828.419% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -16412.153% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -7854.29% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | -644.719% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -5300.55% |
| Vaxxinity, Inc. | -58.28 Million USD | -7172.883% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -3987.398% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -18949.003% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -4805.342% |
| NexImmune, Inc. | -29.19 Million USD | -14420.863% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -75325.275% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -28971.326% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 204.742% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -16550.3% |
| Scopus BioPharma Inc. | -11.71 Million USD | -36084.759% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -3236.167% |
| Ainos, Inc. | -13.2 Million USD | -31998.083% |
| Pluri Inc. | -22.15 Million USD | -19030.788% |
| Prothena Corporation plc | -191.03 Million USD | -2118.953% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -2970.894% |
| Celularity Inc. | -192.28 Million USD | -2104.517% |
| Rallybio Corporation | -78.93 Million USD | -5270.445% |
| Cue Biopharma, Inc. | -52.14 Million USD | -8028.631% |
| MeiraGTx Holdings plc | -137.06 Million USD | -2992.784% |
| Omeros Corporation | -164.53 Million USD | -2476.43% |
| Humacyte, Inc. | -100.04 Million USD | -4137.009% |
| Immunocore Holdings plc | -59.64 Million USD | -7006.573% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -22740.67% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -17214.055% |
| Blueprint Medicines Corporation | -486.27 Million USD | -771.725% |
| CalciMedica, Inc. | -21.87 Million USD | -19278.286% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -5577.739% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -3123.942% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -2374.678% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -1196.727% |
| Pulmatrix, Inc. | -14.74 Million USD | -28658.48% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -11759.001% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -4670.103% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -722.642% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -6175.259% |
| Cytokinetics, Incorporated | -496.2 Million USD | -754.284% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -12215.872% |
| Nutriband Inc. | -4.87 Million USD | -86908.711% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -9619.579% |
| Vor Biopharma Inc. | -126.03 Million USD | -3263.325% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 199.929% |
| Evogene Ltd. | -26.39 Million USD | -15962.294% |
| ProKidney Corp. | -151.52 Million USD | -2697.614% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -6468.529% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -55007.471% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | -597.927% |
| CorMedix Inc. | -48.95 Million USD | -8558.479% |
| BioLineRx Ltd. | -49.69 Million USD | -8430.205% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -3612.787% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -11034.167% |
| Atai Life Sciences N.V. | -125.47 Million USD | -3278.47% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -5092.352% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -5107.041% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -1602.492% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -13689.85% |
| MediciNova, Inc. | -9.9 Million USD | -42717.036% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -3254.356% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -58429.845% |
| GeoVax Labs, Inc. | -26.74 Million USD | -15750.913% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -1728.534% |
| Biomea Fusion, Inc. | -126.13 Million USD | -3260.685% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -1113.216% |
| Mereo BioPharma Group plc | -28.41 Million USD | -14817.652% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -2118.338% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -1743.412% |
| Absci Corporation | -115.51 Million USD | -3569.653% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -15265.933% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -3655.748% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -1650.481% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -16724.099% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -1938.04% |
| Allakos Inc. | -196.05 Million USD | -2062.137% |
| Imunon, Inc. | -21.03 Million USD | -20056.507% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -3730.514% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 4051.269% |
| BioAtla, Inc. | -129.68 Million USD | -3168.639% |
| NLS Pharmaceutics AG | -11.8 Million USD | -35802.239% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -26656.296% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -1193.415% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -10051.348% |
| XOMA Corporation | -41.84 Million USD | -10029.516% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -3928.051% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -3389.032% |
| aTyr Pharma, Inc. | -54.91 Million USD | -7618.64% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -4748.617% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -2352.132% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -1565.946% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -19647.508% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -51514.836% |
| Akari Therapeutics, Plc | -16.8 Million USD | -25123.135% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -47935958.116% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 1355.725% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -64775.815% |
| UroGen Pharma Ltd. | -65.53 Million USD | -6368.201% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -4648.09% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -58264.216% |
| Orgenesis Inc. | -53.63 Million USD | -7803.274% |
| Entera Bio Ltd. | -8.89 Million USD | -47577.427% |
| GH Research PLC | -41.22 Million USD | -10183.344% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -16389.031% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -5003.97% |
| Xencor, Inc. | -138.63 Million USD | -2957.581% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -82137.496% |
| Replimune Group, Inc. | -234.77 Million USD | -1705.574% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -19624.426% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -30282.741% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -64775.815% |
| Portage Biotech Inc. | -18.25 Million USD | -23123.58% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -58429.845% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -3938.643% |
| OncoCyte Corporation | -25.13 Million USD | -16764.258% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -37397.157% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -36899.017% |
| Purple Biotech Ltd. | 22.27 Million USD | 19133.721% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -56329.712% |
| scPharmaceuticals Inc. | -55.39 Million USD | -7552.177% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -22331.309% |
| HilleVax, Inc. | -133.34 Million USD | -3078.972% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -35081.343% |
| Tharimmune, Inc. | -9.45 Million USD | -44732.378% |
| Genprex, Inc. | -31.07 Million USD | -13540.94% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -2152.463% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -13409.896% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -554017.647% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -77723.812% |
| OKYO Pharma Limited | -15.74 Thousand USD | -26914647.11% |
| Savara Inc. | -60 Million USD | -6964.176% |
| Curis, Inc. | -48.33 Million USD | -8670.587% |
| Daré Bioscience, Inc. | -30.83 Million USD | -13645.19% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -81149.233% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -58152.027% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -15455.963% |
| BeiGene, Ltd. | -1.2 Billion USD | -250.987% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -21159.523% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -770.101% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -4426.332% |
| Erasca, Inc. | -141.52 Million USD | -2895.231% |
| bluebird bio, Inc. | -244.26 Million USD | -1635.432% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -93538.709% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 2280.096% |
| DBV Technologies S.A. | -76.43 Million USD | -5446.106% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -93538.709% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -9848.602% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -66550.943% |
| Molecular Templates, Inc. | -10.46 Million USD | -40402.58% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -6204.564% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -1025.167% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -2857.903% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -8053.021% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -2642.944% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -1936.708% |
| MacroGenics, Inc. | -168.24 Million USD | -2419.555% |
| RenovoRx, Inc. | -11.39 Million USD | -37097.262% |
| Adicet Bio, Inc. | -152.03 Million USD | -2688.119% |
| Prime Medicine, Inc. | -191.29 Million USD | -2115.984% |
| Aditxt, Inc. | -26.06 Million USD | -16164.795% |
| Adagene Inc. | -23.71 Million USD | -17771.096% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -57888.279% |
| Quantum-Si incorporated | -111.17 Million USD | -3713.045% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -13294.211% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -28978.526% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 3574.191% |
| SciSparc Ltd. | -5.77 Million USD | -73328.027% |
| Vericel Corporation | -6.46 Million USD | -65478.589% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -48868.055% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -18235.111% |
| Generation Bio Co. | -138.56 Million USD | -2959.258% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -5005.384% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -4802.845% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -1658.184% |
| Invivyd, Inc. | -207.78 Million USD | -1940.109% |
| Relay Therapeutics, Inc. | -373 Million USD | -1036.461% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -45099.106% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 19833.718% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -41107.349% |
| 2seventy bio, Inc. | -216.7 Million USD | -1856.134% |
| ADMA Biologics, Inc. | 21.63 Million USD | 19695.969% |
| Clene Inc. | -40.54 Million USD | -10356.339% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -17505.386% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -7635.966% |
| GeoVax Labs, Inc. | -26.74 Million USD | -15750.913% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -1110.935% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -11440.341% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 26466.859% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -3987.674% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -12366.914% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -2389.458% |
| Vir Biotechnology, Inc. | -684.3 Million USD | -519.461% |
| Evaxion Biotech A/S | -22.19 Million USD | -18997.175% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -5045.542% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -1799.84% |
| Trevena, Inc. | -35.28 Million USD | -11912.582% |
| Surrozen, Inc. | -45.78 Million USD | -9159.502% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -5202.395% |
| Cingulate Inc. | -22.75 Million USD | -18525.443% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 56680.352% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -9390.228% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -51382.03% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -4033.271% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -5676.857% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -6728.946% |
| Clearmind Medicine Inc. | -8.74 Million USD | -48393.653% |
| Kronos Bio, Inc. | -121.83 Million USD | -3379.439% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -5463.284% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -144428.526% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -4104.231% |
| Statera Biopharma, Inc. | -98.34 Million USD | -4210.389% |
| ImmunityBio, Inc. | -362.25 Million USD | -1070.186% |
| Korro Bio, Inc. | -84.53 Million USD | -4914.55% |
| Kineta, Inc. | -15.72 Million USD | -26860.504% |
| BioVie Inc. | -32.17 Million USD | -13072.948% |
| Codexis, Inc. | -68.06 Million USD | -6127.504% |
| Celularity Inc. | -192.28 Million USD | -2104.517% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -1804.244% |
| Celcuity Inc. | -66.23 Million USD | -6300.391% |
| Virax Biolabs Group Limited | -6.49 Million USD | -65150.791% |
| Cibus, Inc. | -318.88 Million USD | -1229.328% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -9758.14% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -12425.115% |
| IN8bio, Inc. | -30.33 Million USD | -13873.036% |
| Kodiak Sciences Inc. | -277.32 Million USD | -1428.554% |
| Annexon, Inc. | -143.72 Million USD | -2849.424% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -3324.32% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -6457.25% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -17981.385% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -1098.372% |
| Eyenovia, Inc. | -25.4 Million USD | -16584.742% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 13087.132% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -76113.592% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -5256.804% |
| Arcellx, Inc. | -89.88 Million USD | -4616.288% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -9234.537% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -2989.493% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -13526.282% |
| Moolec Science SA | -6.65 Million USD | -63607.908% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -6833.495% |
| Geron Corporation | -193.94 Million USD | -2085.682% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -9700.476% |
| Royalty Pharma plc | 1.49 Billion USD | 384.087% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -2482.205% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -45344.478% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -19260.883% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -2379.571% |
| Humacyte, Inc. | -100.04 Million USD | -4137.009% |
| Structure Therapeutics Inc. | -102.77 Million USD | -4024.544% |
| 89bio, Inc. | -151.2 Million USD | -2703.497% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -5190.021% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -29054.058% |
| Genelux Corporation | -24.16 Million USD | -17441.899% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -12395.947% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -2368.122% |
| Notable Labs, Ltd. | -14.65 Million USD | -28821.335% |
| Liquidia Corporation | -73.38 Million USD | -5676.464% |
| Mustang Bio, Inc. | -50.72 Million USD | -8256.661% |
| Immunovant, Inc. | -282.7 Million USD | -1399.422% |
| Quantum-Si incorporated | -111.17 Million USD | -3713.045% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -5327.448% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -19832.289% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -4055.393% |
| Acasti Pharma Inc. | -11.31 Million USD | -37373.479% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -18393.873% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -26427.969% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -1880.341% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -115433.301% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -26583.873% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -14438.533% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -10143.089% |
| PepGen Inc. | -84.76 Million USD | -4900.826% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -14205.963% |
| United Therapeutics Corporation | 1.18 Billion USD | 457.752% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -18413.342% |
| Solid Biosciences Inc. | -104.31 Million USD | -3963.653% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -12820.583% |
| Immuneering Corporation | -58.41 Million USD | -7156.96% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -83177.082% |
| Silo Pharma, Inc. | -3.85 Million USD | -109844.206% |
| Belite Bio, Inc | -31.66 Million USD | -13285.752% |
| XOMA Corporation | -41.84 Million USD | -10029.516% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -6178.14% |
| Bionomics Limited | -17.89 Billion USD | 76.308% |
| Apogee Therapeutics, Inc. | -93 Million USD | -4457.917% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 11980.605% |
| uniQure N.V. | -282.87 Million USD | -1398.563% |
| Cassava Sciences, Inc. | -105.95 Million USD | -3900.68% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -57888.279% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -3173.258% |
| Forte Biosciences, Inc. | -32.48 Million USD | -12948.698% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -50918.474% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -14320.82% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -76113.592% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -29731.105% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -47588.154% |
| Altimmune, Inc. | -95.92 Million USD | -4318.893% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -5667.818% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 11980.605% |
| Compugen Ltd. | -12.99 Million USD | -32527.771% |
| Peak Bio, Inc. | -1356.23 USD | -312557504.536% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -8445.682% |
| Benitec Biopharma Inc. | -22.49 Million USD | -18748.377% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -1649.462% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -14150.656% |
| Zura Bio Limited | -62.63 Million USD | -6667.457% |
| PolyPid Ltd. | -22.86 Million USD | -18437.631% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -25944.483% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -14150.656% |
| Instil Bio, Inc. | -159.16 Million USD | -2563.207% |
| argenx SE | -425.04 Million USD | -897.297% |
| Immunome, Inc. | -109.53 Million USD | -3770.173% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -8316.893% |
| Verona Pharma plc | -67.83 Million USD | -6149.364% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -16166.309% |
| Shattuck Labs, Inc. | -91.95 Million USD | -4509.763% |
| CervoMed Inc. | -7.81 Million USD | -54156.457% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -5698.112% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -31721.935% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -8699.352% |
| Moolec Science SA | -6.65 Million USD | -63607.908% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -25671.441% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -3034.737% |
| AnaptysBio, Inc. | -164.41 Million USD | -2478.295% |
| Design Therapeutics, Inc. | -78.19 Million USD | -5321.409% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -4770.119% |
| NeurAxis, Inc. | -6.66 Million USD | -63505.72% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -10366.925% |
| Lumos Pharma, Inc. | -36.61 Million USD | -11477.539% |
| Achilles Therapeutics plc | -75.25 Million USD | -5532.848% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -16166.309% |
| 180 Life Sciences Corp. | -13.47 Million USD | -31352.421% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 82309.937% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -144428.526% |
| Nutriband Inc. | -4.87 Million USD | -86908.711% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -3726.503% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -7544.863% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -8238.579% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -6313.108% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -7732.146% |
| Palisade Bio, Inc. | -13.07 Million USD | -32333.053% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -9235.154% |
| Beam Therapeutics Inc. | -176.48 Million USD | -2301.904% |
| Neurogene Inc. | -55.58 Million USD | -7526.433% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -3783.504% |
| AEON Biopharma, Inc. | -48.42 Million USD | -8653.02% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -4283.208% |
| Sesen Bio, Inc. | -25.9 Million USD | -16261.11% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -4974.884% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -33577.882% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -820.403% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -5751.82% |
| Athira Pharma, Inc. | -125.46 Million USD | -3278.605% |
| Vaccinex, Inc. | -22.88 Million USD | -18423.05% |
| HCW Biologics Inc. | -25.71 Million USD | -16383.158% |
| XOMA Corporation | -41.84 Million USD | -10029.516% |
| Nektar Therapeutics | -137.42 Million USD | -2984.592% |
| Arvinas, Inc. | -401.5 Million USD | -955.791% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -47935958.116% |
| Merus N.V. | -156.54 Million USD | -2607.813% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -4127.965% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -12144.367% |
| Rezolute, Inc. | -70.42 Million USD | -5919.34% |
| Clene Inc. | -40.54 Million USD | -10356.339% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -25781.532% |
| BeyondSpring Inc. | -23.11 Million USD | -18239.534% |
| Synlogic, Inc. | -55.16 Million USD | -7584.777% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -23543.26% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -39062.971% |
| Peak Bio, Inc. | -1356.23 USD | -312557504.536% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -10365.891% |
| Krystal Biotech, Inc. | -109.72 Million USD | -3763.224% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -3172.348% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -1135.813% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -89218.204% |
| MannKind Corporation | 8.67 Million USD | 48947.661% |
| Ikena Oncology, Inc. | -75.41 Million USD | -5520.749% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -43841.122% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -6205.221% |
| Gossamer Bio, Inc. | -183.75 Million USD | -2206.826% |
| CohBar, Inc. | -12.38 Million USD | -34117.778% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -8256.991% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -15265.933% |
| Legend Biotech Corporation | -439.48 Million USD | -864.538% |
| Mural Oncology plc | -194.63 Million USD | -2077.889% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -6213.391% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -26155.368% |
| Disc Medicine, Inc. | -91.12 Million USD | -4551.852% |
| Champions Oncology, Inc. | -7.35 Million USD | -57526.427% |
| REGENXBIO Inc. | -268.12 Million USD | -1480.961% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -39449.599% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -7502.769% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -10780.211% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -3606.813% |
| Vaxart, Inc. | -83.34 Million USD | -4985.966% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -49653.474% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -9805.575% |
| Cellectis S.A. | -106.62 Million USD | -3875.578% |
| Longeveron Inc. | -21.02 Million USD | -20057.877% |
| Repare Therapeutics Inc. | -116.22 Million USD | -3547.267% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -1482.756% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -5503.807% |
| Revolution Medicines, Inc. | -487.18 Million USD | -770.101% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -63625.195% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -9544.173% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -5583.067% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -5987.456% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -38397.866% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 198.41% |
| Denali Therapeutics Inc. | -196.69 Million USD | -2055.069% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -48868.055% |
| Veru Inc. | -93.78 Million USD | -4420.047% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -18070.517% |
| Cingulate Inc. | -22.75 Million USD | -18525.443% |
| Passage Bio, Inc. | -108.38 Million USD | -3810.913% |
| Context Therapeutics Inc. | -25.07 Million USD | -16806.892% |
| Exicure, Inc. | -14.99 Million USD | -28167.538% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -1957.128% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -10341.401% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -43524.858% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -2199.343% |
| Nuvalent, Inc. | -149.49 Million USD | -2735.603% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -51491.254% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -4677.361% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -20305.314% |
| OmniAb, Inc. | -69.41 Million USD | -6006.397% |
| Anew Medical, Inc. | -1.3 Million USD | -325766.363% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -33092.389% |
| Lipocine Inc. | -17.93 Million USD | -23540.679% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -6087.147% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -5466.499% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -11033.196% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -10624.315% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -18837.634% |
| Sage Therapeutics, Inc. | -579.84 Million USD | -631.052% |
| Ocugen, Inc. | -65.53 Million USD | -6368.694% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -4416.012% |
| Q32 Bio Inc. | -92.1 Million USD | -4502.506% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -19672.377% |
| Alumis Inc. Common Stock | -158.17 Million USD | -2579.96% |
| Equillium, Inc. | -14.52 Million USD | -29090.194% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -6692.616% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -53535.49% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -22370.054% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -8928.562% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -3808.137% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -35313.489% |
| Dominari Holdings Inc. | -21.79 Million USD | -19348.523% |
| Edesa Biotech, Inc. | -9.22 Million USD | -45862.39% |
| vTv Therapeutics Inc. | -25.5 Million USD | -16522.226% |
| Bio-Techne Corporation | 206.68 Million USD | 2150.937% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -982.795% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 2307.468% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -3104.639% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -10941.65% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -2705.408% |
| Nkarta, Inc. | -131.65 Million USD | -3119.901% |
| BioCardia, Inc. | -11.64 Million USD | -36305.015% |
| Iterum Therapeutics plc | -47.46 Million USD | -8830.227% |